Abstract

Transdermal Delivery of Nisoldipine: Refinement of Vehicles

Author(s): El Maghraby Gamal M, Ahmed Amal A, Osman Mohamed A

Issue: Mar/Apr 2015 - Volume 19, Number 2

Page(s): 152-160

Download in electronic PDF format for $75
  • Transdermal Delivery of Nisoldipine: Refinement of Vehicles Page 1
  • Transdermal Delivery of Nisoldipine: Refinement of Vehicles Page 2
  • Transdermal Delivery of Nisoldipine: Refinement of Vehicles Page 3
  • Transdermal Delivery of Nisoldipine: Refinement of Vehicles Page 4
  • Transdermal Delivery of Nisoldipine: Refinement of Vehicles Page 5
  • Transdermal Delivery of Nisoldipine: Refinement of Vehicles Page 6
  • Transdermal Delivery of Nisoldipine: Refinement of Vehicles Page 7
  • Transdermal Delivery of Nisoldipine: Refinement of Vehicles Page 8
  • Transdermal Delivery of Nisoldipine: Refinement of Vehicles Page 9

Abstract

Nisoldipine is used for the treatment of hypertension and angina pectoris. However, it has very low bioavailability, which is attributed to extensive pre-systemic metabolism. In addition, nisoldipine is highly potent (used at a low dose). Taking into consideration the fact that transdermal delivery avoids the pre-systemic metabolism and is only suitable for potent drugs, nisoldipine can be considered as an excellent candidate for transdermal delivery. Accordingly, the purpose of this study was to optimize nisoldipine transdermal delivery. That was achieved initially by investigating the effect of vehicles on skin penetration. The tested vehicles were ranked with respect to transdermal flux of nisoldipine as isopropyl myristate > oleic acid > propylene glycol > water > polyethylene glycol 400. A combination of oleic acid with propylene glycol was synergistic with a ratio of 1:2 w/w being the best. These results were taken further to develop microemulsion systems using either oleic acid or isopropyl myristate as the oil phase. Both cases employed polyoxyethylene sorbitan monooleate as a surfactant with propylene glycol being utilized as a cosurfactant in the case of oleic acid and ethanol in the case of isopropyl myristate. The developed microemulsions produced significant enhancement in nisoldipine transdermal delivery with the flux being even greater than that obtained from the corresponding pure vehicles. This achievement was recorded in optimum microemulsion formulations which contained a cosurfactant. The study provided stepwise optimization of a vehicle for transdermal delivery of nisoldipine.

Related Keywords

  • nisoldipine
  • second generation dihydropyridine calcium channel blocker
  • hypertension
  • antihypertensive
  • high blood pressure
  • angina pectoris
  • cardiac chest pain
  • transdermal delivery
  • pure vehicles
  • microemulsions
  • oleic acid
  • isopropyl myristate
  • polyoxyethylene sorbitan monooleate
  • surfactant
  • cosurfactant
  • skin permeation
  • permeability studies
  • transdermal penetration
  • binary vehicle mixtures
  • pseudoternary phase diagrams

Related Categories

  • EXCIPIENTS
  • PEER-REVIEWED
  • CARDIOLOGY
  • DOSAGE FORMS/DRUG CARRIERS

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy		 Title/Author
(Click for Abstract / Details / Purchase)
Mar/Apr 2015
Pg. 152-160
Transdermal Delivery of Nisoldipine: Refinement of Vehicles
Author(s): El Maghraby Gamal M, Ahmed Amal A, Osman Mohamed A
Mar/Apr 2003
Pg. 106-113
Veterinary Transdermal Medications: A to Z
Author(s): Davidson Gigi S
Jan/Feb 2019
Pg. 65-69
Transdermal Delivery of Metformin Hydrochloride from a Semisolid Vehicle
Author(s): Polonini Hudson, Lopes Cândido Paulo José, Andrade Junquiera Laura, Loures Sharlene, Raposo Nádia RB, Fernandes Brandão Marcos Antônio, de Oliveira Ferreira Anderson
Jan/Feb 2001
Pg. 65-67
Oral Liquid Vehicles, Featured Excipient:
Author(s): Allen Loyd V Jr
Sep/Oct 2008
Pg. 392-397
Transdermal Amlodipine Besylate in Lipoderm for the Treatment of Feline Hypertension: A Report of Two Cases
Author(s): Mixon William, Helms Scott R
Nov/Dec 2019
Pg. 494
Verapmail Hydrochloride 50 mg/mL in SyrSpend SF
Author(s): Allen Loyd V Jr
May/Jun 2016
Pg. 250-256
Effect of Penetration Enhancers on the Percutaneous Delivery of Pain Management Actives
Author(s): Trimble John, Light Bob
May/Jun 2023
Pg. 223-229
Sterile Basics: Intravenous Admixture Compounding, Part 2: Parenteral Vehicle Considerations
Author(s): Allen Loyd V Jr
Jan/Feb 2012
Pg. 62-63
The Use of Pluronic Lecithin Organogels in the Transdermal Delivery of Drugs
Author(s): Bramwell Bethany L, Williams LaVonn A
Mar/Apr 2015
Pg. 167-173
Analgesic Efficacy and Transdermal Penetration of Topical Gabapentin Creams: Finding an Optimal Dose and Pre-treatment Time
Author(s): Heustess Allie, Spigener Shuler, Sweitzer Sarah, Romero-Sandoval Alfonso, Asbill Scott
Nov/Dec 2010
Pg. 488-491
Case Report: Management of Secondary Hypertension in a Feline with the Use of Transdermal Prazosin
Author(s): Rudner Shara, Browne Paul
Jan/Feb 2016
Pg. 71-80
A Novel Vehicle for Enhanced Drug Delivery Across the Human Nail for the Treatment of Onychomycosis
Author(s): Turner Rob, Weaver Sean, Caserta Francesco, Brown Marc B
Jan/Feb 2013
Pg. 71
Nicardipine Hydrochloride Injection
Author(s): Allen Loyd V Jr
Jan/Feb 2023
Pg. 30-37
Advanced Compounding: Compounding with Microneedle Arrays, Part 3: Microneedle Array Development in the Literature and Quality Control of Microneedle Arrays
Author(s): Allen Loyd V Jr
Jul/Aug 2023
Pg. 340-346
Formulation and In Vitro Evaluation of a Ramipril Entrapped in a Microsponge-based Drug-delivery System
Author(s): Taghi Hassanien Sagban, Abdulbaqi Mustafa R, Samein Laith Hamza, Rahmani Maha H Philip
Sep/Oct 2019
Pg. 413
Verapamil Hydrochloride 50 mg/mL in Ora-Plus:Ora-Sweet (1:1)
Author(s): Allen Loyd V Jr
May/Jun 2014
Pg. 256-261
Preparation and In Vitro Evaluation of a Pluronic Lecithin Organogel Containing Ricinoleic Acid for Transdermal Delivery
Author(s): Boddu Sai HS, Bonam Sindhu Prabha, Wei Yangjie, Alexander Kenneth
Nov/Dec 2017
Pg. 530-535
Effect of Penetration Enhancers on the Percuaneous Delivery of Hormone Replacement Actives
Author(s): Trimble John O, Light Bob
Sep/Oct 2023
Pg. 424-430
Evaluation of Compounded Transdermal Analgesic Formulations Using the Franz Finite Dose Model
Author(s): Baneshi Marzieh, Tyagi Deependra, Panneerselvam Ezilrani, MacKenzie Graham, Coleman Johngary, Zhang Shine X
Mar/Apr 2018
Pg. 108-121
Personalized Medicine and Customized Drug Delivery Systems: The New Trend of Drug Delivery and Disease Management
Author(s): Soni Abhishek, Gowthamarajan Kuppusamy, Radhakrishnan Arun